Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 11 citing Rathmann: Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. (0.07 sec) 

Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long- …


LB Haas - Journal of the American Medical Directors Association, 2007 - Elsevier
Approximately 25% of patients in nursing homes have diabetes, and it is the primary reason
for 12% of nursing home admissions among residents 45 to 75 years of age. Glycemic control
is important to reduce the risk of diabetic complications in this patient population. ...
Cited by 14 - Related articles - All 12 versions

Direct costs and health-related resource utilisation in the 6 months after insulin …


A Liebl, L Breitscheidel, C Nicolay, M … - … Medical Research and …, 2008 - informahealthcare.com
Results: The percentage of patients using blood glucose monitoring increased from 76.4 to
99.6%; 42.1% of patients remained on oral anti-diabetic medication, with metformin used most
frequently (36.5%). Total average cost of resource use related to diabetes care per patient ...
Cited by 3 - Related articles - All 6 versions

Prevalence and antihyperglycemic prescribing trends for patients with type 2 …


G Mazzaglia, N Yurgin, KS Boye, G Trifirò, S Cottrell … - Pharmacological …, 2008 - Elsevier
To estimate the prevalence of type 2 diabetes in Italy and to investigate patient-related variables
associated with the use of different antihyperglycemic therapies. This study was conducted between
the years 2000–2003 from a source population comprising a cumulative sample of ...
Cited by 2 - Related articles - All 3 versions

Resource utilisation and costs in patients with type 2 diabetes mellitus treated with …


O Schöffski, L Breitscheidel, U Benter, FW … - Journal of Medical …, 2008 - informahealthcare.com
Results: Patients (n=1,024, 512 patients per cohort) were on average 62 years of age, with an
average 8-year diabetes history at study start. The average unadjusted total annual costs per
patient were €1,868.41 (95% CI 1,744.27–1,992.56) for insulin glargine-based vs. ...
Cited by 3 - Related articles - All 4 versions

The impact of diabetes on prescription drug costs: the population-based Turin …


G Bruno, L Karaghiosoff, F Merletti, G Costa, M De … - Diabetologia, 2008 - Springer
Abstract Aims/hypothesis The aim of our study was to compare prescription drug costs in diabetic
and non-diabetic indi- viduals in a large population-based Italian cohort covered by the National
Health System. Methods We identified diabetic residents in Turin on 31 July 2003 through ...
Cited by 1 - Related articles - BL Direct - All 3 versions

Patterns and predictors of statin prescription in patients with type 2 diabetes


HK Berthold, I Gouni-Berthold, M Böhm, W … - Cardiovascular …, 2009 - ncbi.nlm.nih.gov
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Cited by 1

Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of …


WA Scherbaum, G Goodall, KM Erny- … - Cost Effectiveness …, 2009 - resource-allocation.com
Over patient lifetimes pioglitazone treatment improved undiscounted life expectancy by 0.406
years and improved quality-adjusted life expectancy by 0.120 quality-adjusted life years
(QALYs) compared to placebo. Direct medical costs (treatment plus complication costs) ...
Related articles - Cached - All 8 versions

An economic evaluation of anticipated costs and savings of a behavior change …


PN Wiegand, AI Wertheimer - Pharmacy Practice (Internet), 2008 - SciELO Brasil
SciELO - Scientific Electronic Library Online Browse SciELO, SciELO Library Error Detector An
unexpected error occurred in SciELO servers. Click on the SciELO logo to browse the SciELO
Library or use the browser "BACK" button to return to the previous page. ...
Related articles - Cached - All 10 versions

[PDF] Direct Cost of Ambulatory Care of Type 2 Diabetes in the Middle and High Income …


A Kumar, J Nagpal, A Bhartia - JAPI, 2008 - japi.org
Abstract Objective : To estimate the direct cost of ambulatory care in diabetes patients in the middle
and high income group populace of Delhi. Research Design and Methods : We analyzed the
drugs, investigations, consultation and monitoring related data available from a survey of ...
Related articles - View as HTML - All 4 versions

Longitudinal Change in HbA1c in Patients with Type 2 Diabetes: Comparison of …


W Rathmann, K Strassburger, K Kostev, D … - Exp Clin Endocrinol …, 2009 - thieme-connect.com
Research Design and Methods: Longitudinal data from 666 nationwide general and internal
medicine practices in Germany (Disease Analyser, IMS HEALTH) from 7/2004 to 6/2006 were
analysed, including 348 patients (mean age±SD: 61±11 years) with continuous ...
Related articles - All 2 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google